Latest Accuray Incorporated (ARAY) Headlines Ac
Post# of 49
Accuray Shares Up 26.3% Since SmarTrend's Buy Recommendation (ARAY)
Comtex SmarTrend(R) - Mon Mar 10, 9:16AM CDT
SmarTrend identified an Uptrend for Accuray (NASDAQ:ARAY) on November 8th, 2013 at $7.60. In approximately 4 months, Accuray has returned 26.27% as of today's recent price of $9.59.
Accuray Up 23.5% Since SmarTrend Uptrend Call (ARAY)
Comtex SmarTrend(R) - Fri Feb 28, 4:59PM CST
SmarTrend identified an Uptrend for Accuray (NASDAQ:ARAY) on November 8th, 2013 at $7.60. In approximately 4 months, Accuray has returned 23.50% as of today's recent price of $9.38.
Yale prepares for atom smasher's farewell, sets stage for new physics era
M2 - Tue Feb 25, 8:45AM CST
29.6% Return Seen to Date on SmarTrend Accuray Call (ARAY)
Comtex SmarTrend(R) - Fri Feb 21, 11:03AM CST
SmarTrend identified an Uptrend for Accuray (NASDAQ:ARAY) on November 8th, 2013 at $7.60. In approximately 4 months, Accuray has returned 29.56% as of today's recent price of $9.84.
Accuray Has Returned 31.0% Since SmarTrend Recommendation (ARAY)
Comtex SmarTrend(R) - Fri Feb 14, 9:39AM CST
SmarTrend identified an Uptrend for Accuray (NASDAQ:ARAY) on November 8th, 2013 at $7.60. In approximately 3 months, Accuray has returned 31.01% as of today's recent price of $9.95.
Why Did Billionaire Mario Gabelli's Company Sell MAKO Surgical?
Selena Maranjian, The Motley Fool - Motley Fool - Thu Feb 13, 3:42PM CST
The latest 13F season is commencing, when many money managers issue mandatory reports on their holdings. It can be worthwhile to pay attention to these documents, as you might get an investment idea or two by seeing what some major investors have...
Accuray to Participate in Upcoming Investor Conferences
GlobeNewswire - Wed Feb 12, 3:05PM CST
Accuray Incorporated (Nasdaq:ARAY), announced today that its management is scheduled to participate in three upcoming investor conferences.
Latest MD Buyline Ratings Show Significant, Sustained Increase in User Satisfaction for Accuray Incorporated's TomoTherapy® System
PR Newswire - Tue Feb 11, 7:30AM CST
Accuray Incorporated (Nasdaq: ARAY) announced today that overall user satisfaction for its TomoTherapy® System has increased for the fifth consecutive quarter, according to the Q4 2013 MD Buyline Market Intelligence Briefing(TM). In addition, the latest report illustrates Accuray has exceeded market average for user satisfaction among linear accelerator vendors for the second consecutive quarter.
Vemma® Nutrition Company Products Honored For Outstanding Packaging Design
PR Newswire - Tue Feb 11, 7:00AM CST
Vemma Nutrition Company is proud to announce that two of its products, Vemma and Verve Bold, have been honored by BRAND PACKAGING Magazine in its 2013 Design Gallery. BRAND PACKAGING is the only publication entirely focused on the role of packaging in the consumer product marketing mix. Its Design Gallery recognizes packaging that most effectively tells a brand's story through design and structure to connect with consumers. Verve Bold was one of seven products featured in the Metal category and Vemma one of ten in the Rigid Plastic category.
Uptrend Call Working As Accuray Stock Rises 34.4% (ARAY)
Comtex SmarTrend(R) - Fri Feb 07, 9:10AM CST
SmarTrend identified an Uptrend for Accuray (NASDAQ:ARAY) on November 8th, 2013 at $7.60. In approximately 3 months, Accuray has returned 34.43% as of today's recent price of $10.21.
Insider Trading Alert - WYNN, WBS, ARAY, REGN And RGA Traded By Insiders
at The Street - Fri Feb 07, 9:00AM CST
Stocks with insider trader activity include WYNN, WBS, ARAY, REGN and RGA
Why Accuray Incorporated (ARAY) Could be Positioned for a Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 06, 7:44AM CST
Accuray Incorporated could be an interesting play for investors as it is witnessing solid activity on the earnings estimate revision front
Deloitte CEO Barry Salzberg Joins Board of Venture Philanthropy Organization New Profit
PR Newswire - Tue Feb 04, 8:00AM CST
Barry Salzberg, CEO of Deloitte Touche Tohmatsu Limited (DTTL), has been elected to the Board of Directors of New Profit Inc., a pioneering venture philanthropy and social innovation organization.
Accuray Sees Narrower Loss, Hits 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 03, 11:57AM CST
Accuray posted a much narrower loss of $5.4 million, or 7 cents per share for the quarter compared with a loss of $25.5 million, or 35 cents per share for the same quarter in the prior fiscal year
Accuray (ARAY) Catches Eye: Stock Jumps 15.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 03, 8:04AM CST
Accuray Incorporated was a big mover last session, as the company saw its shares rise over 15% on the day.
Nasdaq stocks posting largest percentage increases
AP - Fri Jan 31, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Why Accuray Incorporated Shares Jumped
Sean Williams, The Motley Fool - Motley Fool - Fri Jan 31, 12:57PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Accuray , the developer of radiosurgery...
Why Accuray (ARAY) Hit a Five-Year High Today
at The Street - Fri Jan 31, 11:26AM CST
Accuray ARAY rises on Friday after the radiation oncology company reported its second-quarter earnings results. The company reported gross orders of $80.3 million, while total revenue increased 20% year-over-year to $93.6 million. Gross profit margin...